Activation of the cellular harvey ras gene in mouse skin tumors initiated with urethane
✍ Scribed by Keith Bonham; Travis Embry; David Gibson; Debbie R. Jaffe; Robin A. Roberts; Anne E. Cress; G. Tim Bowden
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 637 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0899-1987
No coin nor oath required. For personal study only.
✦ Synopsis
Mouse skin tumors, benign papillomas, and squamous cell carcinomas (SCCs) were initiated by a single topical application of urethane followed by repeated promotion with 12-0-tetradecanoylphorbol-13-acetate (TPA). Using the NIH 3T3 focus forming assay, dominant transforming activity was detected in DNA isolated from SCC samples. Rearranged and amplified copies o f the C-Ha-fJs gene were detected in NIH 3T3 transformant cell lines, indicating that an activated Ha-ras gene had been transferred t o the NIH 3T3 recipient cells. Analysis of p21ras from the transformant cell lines suggested that the activating ras mutation was present in codon 61. Ultimately, the Ha-ras gene was shown t o be activated by a specific A-;T transversion at the second position of codon 61. This mutation was detected in both benign papillomas and SCCs, suggesting the activation occurred early in tumor development. The results demonstrate a highly consistent activation of the Ha-ras oncogene by a specific point mutation, suggesting a functional role for an activated rasgene in the initiation of mouse skin tumors by urethane.
📜 SIMILAR VOLUMES
## Abstract This study was designed to evaluate the point mutations in the murine c‐Ha‐__ras__ gene of skin papillomas induced by initiation with dibenz[__a,j__]anthracene(DB[__a,j__]A), its bay‐region anti‐diol epoxide ((± anti‐DB[__a,j__]A‐DE), and a 7,14‐dimethyl analogue (7,14‐diMeDB[__a,j__]A)
The human GSTP1 gene is frequently over-expressed in many human cancers and the expression increases with tumor progression and is associated with a more aggressive biology, poor patient survival, and resistance to therapy. The molecular regulation of the human GSTP1 gene during malignancy is, howev